Back to top of page

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

List of required information for application:

- Investigator-initiated exploratory clinical trial proposal

- Description of how the trial aligns with the mission and research interests of the National Institute of Neurological Disorders and Stroke (NINDS)

- Phase 1 and/or Phase 2 study plans for drugs, biologics, devices, surgical, behavioral, or rehabilitation therapies

- Data plan and justification for how the trial will contribute to informing a future trial to establish efficacy (Phase 3, Phase 4, or Pivotal trial)

- Plan for execution of Phase 1 trial(s) and/or early feasibility trial(s), if applicable

- Milestones for transitioning to the UH3 phase, if applicable

- Documentation of successful completion of Phase 1/early feasibility trial(s), if applicable (if not applicable, use Companion FOA XXX)

- For genetic studies, use appropriate FOA (not this FOA)

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows